venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
Published 9 months ago • 125 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:59
the efficacy of venetoclax-based salvage therapy in patients with previously treated r/r aml
-
1:55
outcomes and options for r/r aml patients who fail venetoclax-based salvage therapy
-
2:25
low-intensity venetoclax-based salvage as a bridge to allosct in aml
-
2:08
venetoclax-based quadruplet therapy with trametinib for patients with ras-mutated aml and mds
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
5:52
the power of venetoclax
-
7:50
which aml patients benefit most from venetoclax treatment?
-
9:25
mgus diagnosis: a step-by-step approach
-
1:12
hma in combination with venetoclax and magrolimab in the treatment of aml
-
1:18
venetoclax combination therapies in aml
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
4:11
venetoclax based combination therapy in aml: a real-world retrospective analysis
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:22
select-aml-1: tamibarotene with venetoclax and azacitidine in patients with rara-positive aml
-
2:22
the efficacy of ven-aza salvage therapy compared to azacitidine monotherapy in r/r aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:33
developing targeted therapies to combine with venetoclax in acute myeloid leukemia (aml)
-
2:11
cpx-351 plus venetoclax in patients with newly-diagnosed high-risk aml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
3:42
mechanisms of resistance to venetoclax in aml and methods being explored to overcome these